Experience
Synthon Pharmaceuticals, Inc.
Eli Lilly and Co.; ICOS
Represented Eli Lilly and ICOS in Hatch-Waxman patent litigation concerning ANDA for generic version of drug Adcirca®.
Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.; ICOS , 5:10-cv-00150, E.D.N.C., Judge Dever
Eli Lilly and Co. v. Apotex Inc.
Eli Lilly and Company
Sun Pharmaceutical Inds. v. Eli Lilly and Co.
Eli Lilly and Company
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
Eli Lilly and Company v. Sicor Pharmaceuticals, Inc.
Eli Lilly and Company
Certain Gemcitabine and Products Containing Same
Eli Lilly and Company
Alzheimer's Institute of America, Inc. v. Eli Lilly and Company
Eli Lilly and Company
GlaxoSmithKline v. Synthon Pharmaceuticals, Inc.
GlaxoSmithKline
Hospira, Inc. v. Eli Lilly and Co.
Eli Lilly and Co.
Eli Lilly & Co. v. Wockhardt Ltd.
Eli Lilly and Company
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.